Difluorinated thromboxane A2 reveals crosstalk between platelet activatory and inhibitory pathways by targeting both the TP and IP receptorsBRITISH JOURNAL OF PHARMACOLOGYIF7.72024-06-050OA
Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodiesJOURNAL OF AUTOIMMUNITYIF72016-11-01128OAAI
Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classificationANNALS OF THE RHEUMATIC DISEASESIF20.62016-11-01209OAAI
AUTOANTIBODIES PRECEDE INTERFERON ELEVATION IN PRE-CLINICAL LUPUSANNALS OF THE RHEUMATIC DISEASESIF20.62014-06-010PREAI
Progress Toward Personalized Treatment of Rheumatoid ArthritisCLINICAL PHARMACOLOGY & THERAPEUTICSIF5.52012-08-2214PREAI
Improving the Use of Allopurinol in Chronic Gout: Monitoring Oxypurinol Levels to Guide TherapyCLINICAL PHARMACOLOGY & THERAPEUTICSIF5.52011-09-014OAAI
Anti-ribonucleoprotein antibodies mediate enhanced lung injury following mesenteric ischemia/reperfusion in Rag-1-/- miceAUTOIMMUNITYIF3.12009-07-0721PREAI
Anti-RNP immunity: Implications for tissue injury and the pathogenesis of connective tissue diseaseAUTOIMMUNITY REVIEWSIF8.32007-03-0133PRE
Colonoscopic surveillance of patients with a family history of colon cancer and past history of normal colonoscopy: Is a 5-year interval between colonoscopies appropriate?GASTROINTESTINAL ENDOSCOPYIF7.52000-04-011PREAI